TP53 and colorectal cancer: This study identifies distinct PI3K and TP53 pathway disruptions in early‐onset colorectal cancer among Hispanic/Latino patients, with findings suggesting a higher prevalence of PI3K alterations and potential differences in outcomes associated with TP53 disruptions compared to non‐Hispanic Whites.